Debabrata Bandyopadhyay, MD
Critical Care Medicine · Tampa, FLNPI 1942431135
Payments from drug & device makers
Across 773 payments — averaging $2490.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$1M
- Boehringer Ingelheim$545K
- E.r. Squibb & Sons, L.L.C.$229K
- Roche Products Limited$91K
- ANI Pharmaceuticals, Inc.$31K
- Actelion Pharmaceuticals US, Inc.$5K
- plus $6K from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 497 | $1,017,355 |
| Boehringer Ingelheim | 136 | $545,274 |
| E.r. Squibb & Sons, L.L.C. | 9 | $229,335 |
| Roche Products Limited | 24 | $90,651 |
| ANI Pharmaceuticals, Inc. | 45 | $31,428 |
| Actelion Pharmaceuticals US, Inc. | 17 | $5,233 |
| Boehringer Ingelheim International GmbH | 2 | $3,778 |
| Genentech, Inc. | 9 | $691 |
| Mallinckrodt Hospital Products Inc. | 5 | $296 |
| Abiomed | 2 | $243 |
| Astellas Pharma US Inc | 8 | $227 |
| Innovation Technologies Inc | 1 | $174 |
| Genentech USA, Inc. | 1 | $137 |
| Bayer | 3 | $94 |
| Amgen | 1 | $88 |
| Paragonix Technologies, Inc. | 2 | $65 |
| Boston Scientific | 2 | $53 |
| Sandoz | 1 | $42 |
| Johnson & Johnson | 3 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| Vapotherm Inc | 1 | $24 |
| Atricure, Inc. | 1 | $20 |
| Merck | 1 | $18 |
| Livanova USA, Inc. | 1 | $15 |
How this compares
$1,925,315 in reported general payments places this provider in the 95th percentile of 618 critical care medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Tampa
- Jeffrey LevyHollywood$19M
- Ahmad AswadMiami$6.6M
- George DuvallVero Beach$6M
- Fortune AlabiKissimmee$3.2M
- Carlos VacaMiami$3M
- Christopher HardenGainesville$713K
- Fred UmehKissimmee$682K
- Ali AtayaGainesville$672K
- George AzarFt Lauderdale$669K
- Louis GuzziOrlando$635K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.